LLY
802.55
-2.25%↓
UNH
569.62
+1.64%↑
NVO
126.83
-0.63%↓
JNJ
160.55
+0.48%↑
MRK
125.13
-0.6%↓
LLY
802.55
-2.25%↓
UNH
569.62
+1.64%↑
NVO
126.83
-0.63%↓
JNJ
160.55
+0.48%↑
MRK
125.13
-0.6%↓
LLY
802.55
-2.25%↓
UNH
569.62
+1.64%↑
NVO
126.83
-0.63%↓
JNJ
160.55
+0.48%↑
MRK
125.13
-0.6%↓
LLY
802.55
-2.25%↓
UNH
569.62
+1.64%↑
NVO
126.83
-0.63%↓
JNJ
160.55
+0.48%↑
MRK
125.13
-0.6%↓
LLY
802.55
-2.25%↓
UNH
569.62
+1.64%↑
NVO
126.83
-0.63%↓
JNJ
160.55
+0.48%↑
MRK
125.13
-0.6%↓
Overview
Share price change
24h
Current
Min
68.07
Max
68.52
Recommendations | Neutral |
---|---|
12 Months Forecast | +4.4 upside |
Next Earnings | 1 sie 2024 |
---|
Technical Score
By Trading Central
Confidence
Weak Bearish Evidence
67.93 / 68.19379 Support & Resistance
Axonics Inc Chart
Related News
8 sty 2024, 16:21 UTC
Axonics Shares Climb 20% After Acquisition by Boston Scientific
DJ
Read
8 sty 2024, 12:26 UTC
Boston Scientific To Acquire Axonics For About $3.7 Billion
DJ
Read
8 sty 2024, 15:59 UTC
Ambrx Snags $2 Billion Takeover, But CEO Dan O'Connor Says Don't Call It 'Hot' -- IBD
DJ
Read
8 sty 2024, 14:19 UTC
J&J, Merck, Boston Scientific Debut Trio Of Splashy Takeovers Topping $3 Billion In Value -- IBD
DJ
Read
8 sty 2024, 13:18 UTC
Axonics Stock Soars. It's Being Acquired By Boston Scientific In $3.7 Billion Deal. -- Barrons.com
DJ
Read
8 sty 2024, 12:12 UTC
Boston Scientific: Acquisition Impact to GAAP EPS Expected to Be Less Accretive, or More Dilutive, Due to Amortization Expense and Acquisition-Related Net Charges >BSX
DJ
Read
8 sty 2024, 12:12 UTC
Boston Scientific Sees Acquisition Impact to Adj EPS Immaterial in 2024 and Accretive Thereafter >BSX
DJ
Read
8 sty 2024, 12:11 UTC
Boston Scientific: Axonics' Rev Growth Profile Is Anticipated to Be Highly Accretive to BSX Urology Business in 2024 >BSX
DJ
Read
8 sty 2024, 12:11 UTC
Boston Scientific: Axonics Expects to Deliver Net Rev of About $366 M in 2023 >BSX
DJ
Read
8 sty 2024, 12:11 UTC
Boston Scientific To Acquire Axonics For About $3.7 Bln
DJ
Read
8 sty 2024, 12:10 UTC
Axonic's Stock Soars After Cash Buyout Deal With Boston Scientific Valued At $3.7 Billion -- MarketWatch
DJ
Read
8 sty 2024, 12:02 UTC
Boston Scientific: Deal Reflects Equity Value of About $3.7B and Enterprise Value of About $3.4B
DJ
Read
8 sty 2024, 12:02 UTC
Boston Scientific: Acquisition to Expand Urology Portfolio With Differentiated Technologies to Treat Urinary and Bowel Dysfunction >BSX
DJ
Read
8 sty 2024, 12:02 UTC
Boston Scientific to Buy Axonics for $71 in Cash Per Share >BSX AXNX
DJ
Read
8 sty 2024, 12:01 UTC
Axonics to Be Acquired for $71/Share; Closed Friday at $57.57 >BSX AXNX
DJ
Read
8 sty 2024, 12:01 UTC
Axonics to Be Acquired by Boston Scientific for About $3.7 Billion >BSX AXNX
DJ
Read
8 sty 2024, 12:01 UTC
Axonics to Be Acquired by Boston Scientific for $71/Share Cash >BSX AXNX
DJ
Read
8 sty 2024, 12:00 UTC
Boston Scientific Announces Agreement To Acquire Axonics, Inc. >BSX AXNX
DJ
Read
8 sty 2024, 12:00 UTC
Axonics Announces Definitive Agreement To Be Acquired By Boston Scientific >AXNX BSX
DJ
Read
Peer Comparison
Price change
Axonics Inc Forecast
Price Target
By TipRanks
12 Months Forecast
Average 71 USD 4.4%
High 71 USD
Low 71 USD
Based on 3 Wall Street analysts offering 12 month price targets forAxonics Inc - Dist in the last 3 months.
Rating Consensus
By TipRanks
Neutral
3 ratings
0
Buy
3
Hold
0
Sell
Based on 3 analysts giving stock ratings to Axonics Inc - Dist in the past 3 months.
Technical Score
By Trading Central
Short Term
Weak Bearish Evidence
Bearish events outweigh bullish events.
Intermediate Term
No Evidence
There are no events.
Long Term
Weak Bullish Evidence
All events are bullish.